tirzepatide for depression GLP-1s linked to lower rates of anxiety and than an older anti-obesity drug — not higher. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #MentalHealth #Anxiety #Depression #Neuropsychiatry #ObesityTreatment #WeightManagement #Naltrexone semaglutide depression side effects Once-weekly

What the Research Recommends A 2025 narrative review published in PMC titled "Dietary supplement considerations during glucagon-like peptide-1 receptor agonist treatment" provided specific, evidence-based recommendations for supplement use during GLP-1 therapy

It is still under investigation and has not yet entered Phase 3 obesity trials in the UK

Excess weight remains one of the more modifiable contributors to that risk

These problems are less commonly reported in the literature, but case studies have demonstrated a potential link between GLP-1-induced vomiting and reflux

As noted in the slide bioavailability was high at 79% but there is a small reduction and delay in absorption when taking the medication with food